New: the shifts that come back across the latest research. See what to focus on

Horizon: now

Biology gets cheaper but production remains difficult

DNA tools and AI are making biological products faster and cheaper to develop, but producing them at scale remains difficult.

In the report's words: “Advances in DNA tools and AI are making biological products faster and cheaper to develop, but commercial scale-up remains difficult.”p8–9

The number that matters

64%p45

Startups struggling to improve growth media and production conditions

Where to focus

  1. 1Test how cells behave at larger production volumesp45
  2. 2Secure buyer commitments to support fundingp44
  3. 3Gather evidence of products' environmental benefitsp56

The details

Who it affects

Founders and technical leaders at engineering biology startups; company size unspecified.p6, p66

What holds them back

  • Startup technical leaders struggle to scale production because cellular behavior is hard to predict at larger volumes.p45
  • Startup founders struggle to secure funding because long commercialization timelines and uncertain buyer commitments deter financing.p44
  • Startup leaders struggle to prove environmental benefits because supporting models and data are still emerging.p56

The numbers

  • 64% of startups cite difficulties optimizing growth media and production conditions.p45
  • 63% of startups face financing challenges linked to risks or uncertainties.p44

What people search for

  • fermentation scale up help
  • fermentation process optimization
  • biotech startup funding
  • how to get buyers before scaling production
  • life cycle assessment for fermentation products
  • carbon footprint calculator for bio based products